Home
About us
News
Products
Innovation
CMO/CDMO Services
Contact
中文
undefined
The First Industry-Education Integration Community for the Biopharmaceutical Industry in Central and Southern China Established!
Recently, a founding meeting was held for the Industry-Education Integration Community for the Biopharmaceutical Industry in Central and Southern China, initiated by Jiudian Pharmaceutical, Hunan Chemical Vocational Technology College, and University of South China. Over 100 participants from 71 organizations, including industry enterprises, universities, vocational colleges, and research institutes from across the country, gathered to discuss the integration of industry and education, and to jointly build a new ecosystem for talent development in the biopharmaceutical sector.
21
2025
/
10
Jiudian Pharmaceutical Marks 8th Listing Anniversary United for Shared Prosperity, Embarking on a New Journey
Time is measured in two ways: one by the stopwatch, tracking precision to 0.01 seconds; the other by the growth rings, engraving the dawns and dusks of 365 days. On October 10, 2017, a resounding bell echoed through the venue, as the stock code "300705" lit up the large screen—announcing our first commitment to the times. Today, if we "rewind" that bell, we can still hear the pulse of that moment: it is the heartbeat of Jiudian, and also the heartbeat of every patient, customer, shareholder, and employee.
United in Purpose, Sailing Toward Success; Quality as Priority, Achieving Excellence
On September 28th, the On-site QA Office of Jiudian Hongyang successfully held a team-building activity themed "United in Purpose, Sailing Toward Success; Quality as Priority, Achieving Excellence". Organized under the overall coordination of supervisor of the On-site QA Office and team leader, this activity aimed to strengthen the entire team's awareness of quality responsibility by conducting in-depth analysis of recent typical customer complaint cases, identify quality risk points in various production workshops, and enhance team collaboration capabilities. Its ultimate goal was to realize the objective of "promoting quality through unity and achieving excellence through win-win cooperation".
30
09
Registration Announcement of Jiudian Hongyang's Pharmaceutical Excipient: Polyacrylic Acid Solution
Recently, a piece of exciting news has emerged: the polyacrylic acid solution (Registration No.: F20250000498) developed by Jiudian Hongyang as a pharmaceutical excipient has successfully obtained the registration certificate from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China.
25
Jiudian Pharma Debuts at Egypt's Pharmaconex Exhibition, Its "Going Global" Strategy Recognized by Hunan Medical Products Administration
Recently, the International Business Development and Cooperation Team of Jiudian Pharma traveled to Cairo, Egypt, to participate in Pharmaconex, the most influential professional pharmaceutical exhibition in the region. This marked Jiudian Pharma's first appearance in the African and Middle Eastern markets, where it demonstrated its strength and charisma on the international stage, garnering widespread attention and positive feedback.
20
Hitting a New High! Jiudian Pharma Rises to 76th Place on Hunan Top 100 Manufacturers List
On September 16, the list of Hunan Top 100 Manufacturing Enterprises in 2024 was released, with Jiudian Pharmaceutical ranking 76th—an increase of 10 places compared to 2023 and a record high in the company’s history. This breakthrough achievement not only demonstrates the remarkable results of the enterprise’s innovation-driven development and industrial upgrading but also reflects the strong growth momentum of Hunan’s biomedical industry cluster.
18
Jiudian Pharmaceutical Successfully Passes Joint Inspection by Drug Administrations of Fujian and Hunan Provinces
Since the implementation of the new Drug Administration Law, a number of drug marketing authorization holder (MAH, Type B Certificate) enterprises have emerged in China. To further implement the main responsibility of MAHs for quality and strengthen the supervision and management of the entrusted/contract manufacturing links of drugs, the National Medical Products Administration (NMPA) successively issued the Announcement on Strengthening the Supervision and Management of Entrusted Production by Drug Marketing Authorization Holders in October 2023 and the Announcement on Strengthening the Supervision and Management of Contract Manufacturing of Drugs (Draft for Comments) in November 2024.
04
Joint Training Conducted by Three Workshops of Jiudian Production Center: Consolidating Foundations to Boost Quality and Efficiency
On August 27th, to comprehensively enhance employees' overall competence and production efficiency, Workshop 300, Workshop 301, and Workshop 302 of Jiudian Production Center jointly organized an employee training session. The training covered multiple dimensions, including corporate culture, GMP knowledge, quality management, and work safety.
28
08